Simple plant‐based production and purification of the assembled human ferritin heavy chain as a nanocarrier for tumor‐targeted drug delivery and bioimaging in cancer therapy
Abstract Nanoparticles are used as carriers for the delivery of drugs and imaging agents. Proteins are safer than synthetic nanocarriers due to their greater biocompatibility and the absence of toxic degradation products. In this context, ferritin has the additional benefit of inherently targeting the membrane receptor transferrin 1, which is overexpressed by most cancer cells. Furthermore, this self‐assembling multimeric protein can be loaded with more than 2000 iron atoms, as well as drugs, contrast agents, and other cargos. However, recombinant ferritin currently costs ~3.5 million € g−1, presumably because the limited number of producers cannot meet demand, making it generally unaffordable as a nanocarrier. Because plants can produce proteins at very‐large‐scale, we developed a simple, proof‐of‐concept process for the production of the human ferritin heavy chain by transient expression in Nicotiana benthamiana. We optimized the protein yields by screening different compartments and 5′‐untranslated regions in PCPs, and selected the best‐performing construct for production in differentiated plants. We then established a rapid and scalable purification protocol by combining pH and heat treatment before extraction, followed by an ultrafiltration/diafiltration size‐based separation process. The optimized process achieved ferritin levels of ~40 mg kg−1 fresh biomass although depth filtration limited product recovery to ~7%. The purity of the recombinant product was >90% at costs ~3% of the current sales price. Our method therefore allows the production of affordable ferritin heavy chain as a carrier for therapeutic and diagnostic agents, which is suitable for further stability and functionality testing in vitro and in vivo..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:120 |
|---|---|
| Enthalten in: |
Biotechnology and Bioengineering - 120(2023), 4, Seite 1038-1054 |
| Beteiligte Personen: |
Knödler, Matthias [VerfasserIn] |
|---|
| Anmerkungen: |
© 2023 Wiley Periodicals LLC. |
|---|
| Umfang: |
17 |
|---|
| doi: |
10.1002/bit.28312 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY015167984 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY015167984 | ||
| 003 | DE-627 | ||
| 005 | 20231111132308.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231111s2023 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/bit.28312 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_BIT_2023_120_4.zip.xml |
| 035 | |a (DE-627)WLY015167984 | ||
| 035 | |a (WILEY)BIT28312 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Knödler, Matthias |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Simple plant‐based production and purification of the assembled human ferritin heavy chain as a nanocarrier for tumor‐targeted drug delivery and bioimaging in cancer therapy |
| 264 | 1 | |c 2023 | |
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2023 Wiley Periodicals LLC. | ||
| 520 | |a Abstract Nanoparticles are used as carriers for the delivery of drugs and imaging agents. Proteins are safer than synthetic nanocarriers due to their greater biocompatibility and the absence of toxic degradation products. In this context, ferritin has the additional benefit of inherently targeting the membrane receptor transferrin 1, which is overexpressed by most cancer cells. Furthermore, this self‐assembling multimeric protein can be loaded with more than 2000 iron atoms, as well as drugs, contrast agents, and other cargos. However, recombinant ferritin currently costs ~3.5 million € g−1, presumably because the limited number of producers cannot meet demand, making it generally unaffordable as a nanocarrier. Because plants can produce proteins at very‐large‐scale, we developed a simple, proof‐of‐concept process for the production of the human ferritin heavy chain by transient expression in Nicotiana benthamiana. We optimized the protein yields by screening different compartments and 5′‐untranslated regions in PCPs, and selected the best‐performing construct for production in differentiated plants. We then established a rapid and scalable purification protocol by combining pH and heat treatment before extraction, followed by an ultrafiltration/diafiltration size‐based separation process. The optimized process achieved ferritin levels of ~40 mg kg−1 fresh biomass although depth filtration limited product recovery to ~7%. The purity of the recombinant product was >90% at costs ~3% of the current sales price. Our method therefore allows the production of affordable ferritin heavy chain as a carrier for therapeutic and diagnostic agents, which is suitable for further stability and functionality testing in vitro and in vivo. | ||
| 700 | 1 | |a Opdensteinen, Patrick |4 aut | |
| 700 | 1 | |a Sankaranarayanan, Ramya Ambur |4 aut | |
| 700 | 1 | |a Morgenroth, Agnieszka |4 aut | |
| 700 | 1 | |a Buhl, Eva Miriam |4 aut | |
| 700 | 1 | |a Mottaghy, Felix M. |4 aut | |
| 700 | 1 | |a Buyel, Johannes Felix |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biotechnology and Bioengineering |g 120(2023), 4, Seite 1038-1054 |w (DE-627)WLY002717190 |x 10970290 |7 nnns |
| 773 | 1 | 8 | |g volume:120 |g year:2023 |g number:4 |g pages:1038-1054 |g extent:17 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 120 |j 2023 |e 4 |h 1038-1054 |g 17 | ||